Triple

Target class: biologic disease-modifying antirheumatic drug
Context triple: [Ixifi, instanceOf, biologic disease-modifying antirheumatic drug]

• A. biologic therapy
  Biologic therapy is a treatment that uses substances made from living organisms or their derivatives to target specific components of the immune system or disease processes.
• B. biologic medicinal product chosen
  A biologic medicinal product is a therapeutic substance derived from living organisms or their components, such as proteins, cells, or tissues, used to prevent, diagnose, or treat diseases.
• C. disease-modifying therapy
  A disease-modifying therapy is a treatment that alters the underlying course or mechanisms of a disease to slow its progression, reduce long-term damage, or change its overall outcome rather than just alleviating symptoms.
• D. immunosuppressive agent
  An immunosuppressive agent is a drug or substance that reduces or inhibits the activity of the immune system to prevent or treat immune-mediated damage, such as in organ transplantation or autoimmune diseases.
• E. Bruton tyrosine kinase inhibitor
  A Bruton tyrosine kinase inhibitor is a targeted small-molecule drug that blocks BTK signaling in B cells to disrupt pathways critical for their activation, proliferation, and survival, primarily used in the treatment of certain B-cell malignancies and autoimmune diseases.
• F. None of above.